643 related articles for article (PubMed ID: 11477558)
1. Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells.
Chen Z; Moyana T; Saxena A; Warrington R; Jia Z; Xiang J
Int J Cancer; 2001 Aug; 93(4):539-48. PubMed ID: 11477558
[TBL] [Abstract][Full Text] [Related]
2. Tumour necrosis factor-alpha (TNF-alpha) transgene-expressing dendritic cells (DCs) undergo augmented cellular maturation and induce more robust T-cell activation and anti-tumour immunity than DCs generated in recombinant TNF-alpha.
Zhang W; Chen Z; Li F; Kamencic H; Juurlink B; Gordon JR; Xiang J
Immunology; 2003 Feb; 108(2):177-88. PubMed ID: 12562326
[TBL] [Abstract][Full Text] [Related]
3. Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes.
von Euw EM; Barrio MM; Furman D; Bianchini M; Levy EM; Yee C; Li Y; Wainstok R; Mordoh J
J Transl Med; 2007 Apr; 5():19. PubMed ID: 17448240
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.
Goldszmid RS; Idoyaga J; Bravo AI; Steinman R; Mordoh J; Wainstok R
J Immunol; 2003 Dec; 171(11):5940-7. PubMed ID: 14634105
[TBL] [Abstract][Full Text] [Related]
5. CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: critical role in migration from the tumor site to draining lymph nodes.
Hirao M; Onai N; Hiroishi K; Watkins SC; Matsushima K; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Apr; 60(8):2209-17. PubMed ID: 10786686
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo.
Scheffer SR; Nave H; Korangy F; Schlote K; Pabst R; Jaffee EM; Manns MP; Greten TF
Int J Cancer; 2003 Jan; 103(2):205-11. PubMed ID: 12455034
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity.
Liu Y; Huang H; Chen Z; Zong L; Xiang J
J Gene Med; 2003 Aug; 5(8):668-80. PubMed ID: 12898636
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
9. Macrophage-derived dendritic cells have strong Th1-polarizing potential mediated by beta-chemokines rather than IL-12.
Zou W; Borvak J; Marches F; Wei S; Galanaud P; Emilie D; Curiel TJ
J Immunol; 2000 Oct; 165(8):4388-96. PubMed ID: 11035076
[TBL] [Abstract][Full Text] [Related]
10. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites.
Dieu MC; Vanbervliet B; Vicari A; Bridon JM; Oldham E; Aït-Yahia S; Brière F; Zlotnik A; Lebecque S; Caux C
J Exp Med; 1998 Jul; 188(2):373-86. PubMed ID: 9670049
[TBL] [Abstract][Full Text] [Related]
11. Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.
He T; Tang C; Xu S; Moyana T; Xiang J
Cell Mol Immunol; 2007 Apr; 4(2):105-11. PubMed ID: 17484804
[TBL] [Abstract][Full Text] [Related]
12. Expression of CCR-7, MIP-3beta, and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities.
Parlato S; Santini SM; Lapenta C; Di Pucchio T; Logozzi M; Spada M; Giammarioli AM; Malorni W; Fais S; Belardelli F
Blood; 2001 Nov; 98(10):3022-9. PubMed ID: 11698286
[TBL] [Abstract][Full Text] [Related]
13. Mobilization of dendritic cell precursors into the circulation by administration of MIP-1alpha in mice.
Zhang Y; Yoneyama H; Wang Y; Ishikawa S; Hashimoto S; Gao JL; Murphy P; Matsushima K
J Natl Cancer Inst; 2004 Feb; 96(3):201-9. PubMed ID: 14759987
[TBL] [Abstract][Full Text] [Related]
14. Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors.
Dauer M; Obermaier B; Herten J; Haerle C; Pohl K; Rothenfusser S; Schnurr M; Endres S; Eigler A
J Immunol; 2003 Apr; 170(8):4069-76. PubMed ID: 12682236
[TBL] [Abstract][Full Text] [Related]
15. DNA array and biological characterization of the impact of the maturation status of mouse dendritic cells on their phenotype and antitumor vaccination efficacy.
Chen Z; Dehm S; Bonham K; Kamencic H; Juurlink B; Zhang X; Gordon JR; Xiang J
Cell Immunol; 2001 Nov; 214(1):60-71. PubMed ID: 11902830
[TBL] [Abstract][Full Text] [Related]
16. The role of PGE(2) in the differentiation of dendritic cells: how do dendritic cells influence T-cell polarization and chemokine receptor expression?
Lee JJ; Takei M; Hori S; Inoue Y; Harada Y; Tanosaki R; Kanda Y; Kami M; Makimoto A; Mineishi S; Kawai H; Shimosaka A; Heike Y; Ikarashi Y; Wakasugi H; Takaue Y; Hwang TJ; Kim HJ; Kakizoe T
Stem Cells; 2002; 20(5):448-59. PubMed ID: 12351815
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effect of MIP-1alpha-recruited dendritic cells on preestablished solid and metastatic tumors.
Cao Q; Jin Y; Jin M; He S; Gu Q; He S; Qiu Y; Ge H; Yoneyama H; Zhang Y
Cancer Lett; 2010 Sep; 295(1):17-26. PubMed ID: 20202744
[TBL] [Abstract][Full Text] [Related]
18. Activated natural killer cell-mediated immunity is required for the inhibition of tumor metastasis by dendritic cell vaccination.
Kim A; Noh YW; Kim KD; Jang YS; Choe YK; Lim JS
Exp Mol Med; 2004 Oct; 36(5):428-43. PubMed ID: 15557815
[TBL] [Abstract][Full Text] [Related]
19. Human dendritic cells engineered to express alpha tumor necrosis factor maintain cellular maturation and T-cell stimulation capacity.
Ye Z; Chen Z; Sami A; El-Gayed A; Xiang J
Cancer Biother Radiopharm; 2006 Dec; 21(6):613-22. PubMed ID: 17257077
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated CD40 ligand gene-engineered dendritic cells elicit enhanced CD8(+) cytotoxic T-cell activation and antitumor immunity.
Liu Y; Zhang X; Zhang W; Chen Z; Chan T; Ali K; Jia Z; Xiang J
Cancer Gene Ther; 2002 Feb; 9(2):202-8. PubMed ID: 11857039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]